December 7, 2021
Ionis Collaborates with AstraZeneca to Develop and Commercialize Eplontersen for ATTR
Read More
December 7, 2021
PacBio and UCLA Health Enter Research Collaboration for Whole Genome Sequencing in Rare Diseases
Read More
December 7, 2021
Recursion Enters Collaboration with Roche and Genentech in Neuroscience and Oncology
Read More
December 6, 2021
Rhythm Enters Licensing Deal with RareStone to Commercialize Rare Obesity Drug in China
Read More
December 3, 2021
AstraZeneca Nixes $8.1 Billion Deal to Take Swedish Orphan Biovitrum Private
Read More
December 3, 2021
Recordati to Acquire EUSA Pharma for $847 Million to Expand Rare Disease Offerings
Read More
December 2, 2021
Astellas and Dyno Partner to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
Read More
November 22, 2021
Vifor Pharma Acquires Sanifit and Inositec to Advance Development Therapies for Vascular Calcification
Read More
November 19, 2021
BridgeBio and Helsinn Form Strategic Collaboration to Co-Develop Novel GPX4 Inhibitor in Multiple Cancers
Read More
November 18, 2021
Novo Nordisk to Acquire Dicerna for $3.3 Billion
Read More
November 18, 2021
Cellevolve Launches with Acclaimed Investors and Pivotal Partnership
Read More
November 16, 2021
Kala Acquires Combangio to Expand its Pipeline Targeting Rare Ocular Surface Diseases
Read More
Load More
X